News & Events

Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at Weill Cornell Medicine, Cornell Tech, Cornell Ann S. Bowers College of Computing and Information Science, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian—offers the prospect of better care for many thousands of patients who may be overlooked due to the...

Taylor Lis couldn’t imagine being anything other than a doctor. Meeting new people every day and helping them live healthier lives is a deep passion of hers—one that has motivated her through the past four years as a medical student at Weill Cornell Medical College.

Now, on National Match Day, Lis learned where she’ll complete her residency training: Children’s Hospital of Pennsylvania for pediatrics, her first choice.

“You think about Match Day from the day you get into med...

Many of health care’s toughest challenges—from delayed diagnoses to inefficient clinical workflows—are waiting for creative solutions. At the Cornell Health AI Hackathon, student teams spent an intense weekend racing to build some of them.

More than 100 students from across Cornell campuses and 17 other universities gathered in New York City March 6–8 for the hackathon. Organized by Entrepreneurship...

As the conflict engulfing the Middle East complicates clinical instruction for medical students at Weill Cornell Medicine-Qatar, medical education leadership in New York has rapidly launched telehealth electives to help students in Doha complete their education.

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The findings highlight the potential importance of these under-studied cells in breast cancer progression.

Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell Medicine investigators. The analysis of the pediatric response to H3N2 and H1N1 influenza A viruses, two of the most common causes of flu, provides insight into the concept of “immune imprinting,” and supports the idea that childhood vaccination, if...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. The findings provide important new insights into why patients with metastatic disease often stop responding to a key class of life-prolonging chemotherapy drugs after initially benefiting. Given that taxanes remain the only chemotherapy agents with demonstrated survival...

State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. Though prescription buprenorphine can be a life-saving treatment that relieves opioid cravings and withdrawal symptoms, adherence to the medication is low.

Published March 6 in JAMA Health Forum, the...

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.

Dr. Ekta Khurana, an associate professor of systems and computational biomedicine at Weill Cornell Medicine, has received a two-year, $1 million Challenge Award from the Prostate Cancer Foundation to work with researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center on an AI-based method for early detection of treatment-resistant prostate tumor subtypes.

Dr. Rohan Jotwani, the Nanette Laitman Education Scholar in Entrepreneurship and an assistant professor of clinical anesthesiology at Weill Cornell Medicine, has been selected for the prestigious Macy Faculty Scholars Program.

One of five educators nationwide to make up the class of 2026, Dr. Jotwani becomes Weill Cornell Medicine’s first-ever Macy Faculty Scholar, and the first anesthesiologist ever to receive...

A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure. Researchers from Weill Cornell Medicine, Rockefeller University, and collaborating institutions offer a unprecedented look into these hidden HIV‑harboring cells and show that some may be more vulnerable to immune destruction than previously believed.

Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a preclinical study by Weill Cornell Medicine investigators.

In the study, published Feb. 23 in Nature Metabolism, the researchers showed that in fat cells called white adipocytes, high levels of fatty acids from fat stores, in the presence of a key enzyme called AAC, can trigger a process that uses fat to...

In an effort to unify the rapidly expanding set of academic activities investigating artificial intelligence (AI), Weill Cornell Medicine is launching a new AI to Advance Medicine initiative.

Encompassing a Dean’s Lecture Series and Dean’s Grant Program, the initiative aims to provide the institutional infrastructure and services needed to support AI use safely and effectively among faculty, staff and students. Additionally, a new...

In the early aughts, when anesthesiologist Dr. Gunisha Kaur, M.D. ’10, was a medical student at Weill Cornell Medicine, she sought to help immigrants who were seeking refuge in the United States after experiencing persecution or torture in their home countries. It’s a passion drawn from a profoundly personal experience: As a daughter of Indian immigrants and an...

The popular diabetes and weight-loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators. The findings may offer comfort to patients concerned about their eye health while taking the drug.

Diabetic retinopathy develops when chronically high blood sugar damages the blood vessels lining the back of the eye and affects...

When food is scarce, stress hormones direct the immune system to operate in “low power” mode to preserve immune function while conserving energy, according to researchers at Weill Cornell Medicine. This reconfiguration is crucial to combating infections amid food insecurity.

“Both famine and infectious disease have been with us throughout our evolutionary history and often occurred at the same time. Yet little is known about how nutrition affects the immune system,” said senior author...

Dr. George Coukos, an internationally renowned expert on cancer immunology, is on a mission to rapidly translate tumor biology research into personalized, cell-based therapies for patients with some of the hardest-to-treat cancers. A new laboratory, part of an innovative collaboration between Weill Cornell Medicine and the Ludwig Institute for Cancer Research, seeks to do just that.

Dr. Coukos, who served as the founding director of the Ludwig Lausanne Branch in Switzerland for the...